Royal Bank of Canada
REUN

Royal Bank of Canada’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Royal Bank of Canada’s Portfolio REUN Stock Details REUN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,091
Closed -$6K – 7927
2023
Q2 		$6K Buy
6,091
+429
+8% +$364 ﹤0.01% 6648
2023
Q1 		$3K Buy
5,662
+402
+8% +$448 ﹤0.01% 6735
2022
Q4 		$4K Sell
5,260
-742
-12% -$1.08K ﹤0.01% 6820
2022
Q3 		$9K Sell
6,002
-84
-1% -$299 ﹤0.01% 6500
2022
Q2 		$26K Buy
6,086
+550
+10% +$2.75K ﹤0.01% 5999
2022
Q1 		$37K Sell
5,536
-144
-3% -$1.2K ﹤0.01% 6280
2021
Q4 		$70K Sell
5,680
-1,867
-25% -$40K ﹤0.01% 6183
2021
Q3 		$173K Buy
+7,547
New +$190K ﹤0.01% 5306

Royal Bank of Canada's REUN Position: Q3 2023 in Review

Royal Bank of Canada sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 6,091 shares — an estimated $6K sold.

Royal Bank of Canada first reported a position in REUN in Q3 2021 and held it in 8 quarters. The position peaked at $173K in Q3 2021. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

  • Royal Bank of Canada reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 6,091 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $6K.
  • Royal Bank of Canada first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 8 quarters.
  • Royal Bank of Canada's Reunion Neuroscience Inc. Common Shares position peaked at $173K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.